» Articles » PMID: 26220478

Development and Applications of Single-cycle Infectious Influenza A Virus (sciIAV)

Overview
Journal Virus Res
Specialty Microbiology
Date 2015 Jul 30
PMID 26220478
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The diverse host range, high transmissibility, and rapid evolution of influenza A viruses justify the importance of containing pathogenic viruses studied in the laboratory. Other than physically or mechanically changing influenza A virus containment procedures, modifying the virus to only replicate for a single round of infection similarly ensures safety and consequently decreases the level of biosafety containment required to study highly pathogenic members in the virus family. This biological containment is more ideal because it is less apt to computer, machine, or human error. With many necessary proteins that can be deleted, generation of single-cycle infectious influenza A viruses (sciIAV) can be achieved using a variety of approaches. Here, we review the recent burst in sciIAV generation and summarize the applications and findings on this important human pathogen using biocontained viral mimics.

Citing Articles

A locally administered single-cycle influenza vaccine expressing a non-fusogenic stabilized hemagglutinin stimulates strong T-cell and neutralizing antibody immunity.

Sadler H, Rijal P, Tan T, Townsend A J Virol. 2025; 99(2):e0033124.

PMID: 39868800 PMC: 11853075. DOI: 10.1128/jvi.00331-24.


Recombinant Influenza A Viruses Expressing Reporter Genes from the Viral NS Segment.

Martinez-Sobrido L, Nogales A Int J Mol Sci. 2024; 25(19).

PMID: 39408912 PMC: 11476892. DOI: 10.3390/ijms251910584.


Generation of single-round infectious rotavirus with a mutation in the intermediate capsid protein VP6.

Kotaki T, Kanai Y, Onishi M, Minami S, Chen Z, Nouda R J Virol. 2024; 98(7):e0076224.

PMID: 38837379 PMC: 11265344. DOI: 10.1128/jvi.00762-24.


High-throughput investigation of genetic design constraints in domesticated Influenza A Virus for transient gene delivery.

Sychla A, Stach C, Roach S, Hayward A, Langlois R, Smanski M bioRxiv. 2024; .

PMID: 38405907 PMC: 10888799. DOI: 10.1101/2024.02.14.580300.


Bacterial Artificial Chromosome Reverse Genetics Approaches for SARS-CoV-2.

Chiem K, Nogales A, Almazan F, Ye C, Martinez-Sobrido L Methods Mol Biol. 2023; 2733:133-153.

PMID: 38064031 DOI: 10.1007/978-1-0716-3533-9_9.


References
1.
Rambaut A, Pybus O, Nelson M, Viboud C, Taubenberger J, Holmes E . The genomic and epidemiological dynamics of human influenza A virus. Nature. 2008; 453(7195):615-9. PMC: 2441973. DOI: 10.1038/nature06945. View

2.
Smith G, Vijaykrishna D, Bahl J, Lycett S, Worobey M, Pybus O . Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature. 2009; 459(7250):1122-5. DOI: 10.1038/nature08182. View

3.
Watanabe T, Watanabe S, Noda T, Fujii Y, Kawaoka Y . Exploitation of nucleic acid packaging signals to generate a novel influenza virus-based vector stably expressing two foreign genes. J Virol. 2003; 77(19):10575-83. PMC: 228515. DOI: 10.1128/jvi.77.19.10575-10583.2003. View

4.
Temperton N, Hoschler K, Major D, Nicolson C, Manvell R, Hien V . A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses. 2009; 1(3):105-12. PMC: 4941878. DOI: 10.1111/j.1750-2659.2007.00016.x. View

5.
kaverin N, Varich N, Sklyanskaya E, Amvrosieva T, Petrik J, Vovk T . Studies on heterotypic interference between influenza A and B viruses: a differential inhibition of the synthesis of viral proteins and RNAs. J Gen Virol. 1983; 64 (Pt 10):2139-46. DOI: 10.1099/0022-1317-64-10-2139. View